EFDID: 431193EFD: View Filing

Issuer: Armis Biopharma, Inc. (0001604801) - D

Accession: 0001604801-22-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001604801
  • Entity Name:
    Armis Biopharma, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    COLORADO
  • Year of Inc:
    Over 5 years ago
  • Address:
    2950 EAST HARMONY
    SUITE 252
    FORT COLLINS, CO 80528
  • Persons:
    Related Persons 8
    Ted Ziemann
    Executive Officer, Director
    Steve Coder
    Executive Officer, Director
    Alan Ruud
    Director
    Alan Smith, Ph.D.
    Director
    Christopher Ruud
    Executive Officer, Director
    Ed Neas, Ph.D.
    Director
    Michael Litwack
    Director
    William Nelson, MD. Ph.D.
    Director
EDGAR: Offering Information
  • Accession Date:
    02/15/2022
  • First Sale Date:
    05/15/2020
  • Offering Amount:
    $8,000,000
  • Amount Sold:
    $5,270,000
  • Amount Remaining:
    $2,730,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Conversion of notes
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:MD
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Armis Biopharma, Inc./s/ Steve CoderSteve CoderChief Financial Officer2022-02-15
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Sep. 15, 2022 431193: 0001604801-22-000002 Armis Biopharma, Inc.
Offer Amount: $10,000,000
Amount Sold: $7,270,000
Remaining: $2,730,000
D Feb. 15, 2022 431193: 0001604801-22-000001 Armis Biopharma, Inc.
Offer Amount: $8,000,000
Amount Sold: $5,270,000
Remaining: $2,730,000